about
Pathogen evolution and disease emergence in carnivoresMolecular mechanisms of severe acute respiratory syndrome (SARS)Functional and genetic analysis of coronavirus replicase-transcriptase proteinsCoronavirus reverse genetic systems: infectious clones and repliconsReassessing Biological Threats: Implications for Cooperative Mitigation StrategiesA complex RNA motif defined by three discontinuous 5-nucleotide-long strands is essential for Flavivirus RNA replicationEmerging and re-emerging viruses in the era of globalisationSolution Structure of Mouse Hepatitis Virus (MHV) nsp3a and Determinants of the Interaction with MHV Nucleocapsid (N) ProteinDetection of airborne viruses using electro-aerodynamic deposition and a field-effect transistorSARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era.The economy-wide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment.Evolutionary ecology of virus emergence.SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome.Electrical detection of single viruses.Molecular mapping of the RNA Cap 2'-O-methyltransferase activation interface between severe acute respiratory syndrome coronavirus nsp10 and nsp16.Analysis of murine hepatitis virus strain A59 temperature-sensitive mutant TS-LA6 suggests that nsp10 plays a critical role in polyprotein processingNeutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technologyEvasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses.Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants.Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.Crystal structure of Middle East respiratory syndrome coronavirus helicase.Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibodyMolecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms.Assembly of severe acute respiratory syndrome coronavirus RNA packaging signal into virus-like particles is nucleocapsid dependent.Contribution of trafficking signals in the cytoplasmic tail of the infectious bronchitis virus spike protein to virus infection.Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes.One severe acute respiratory syndrome coronavirus protein complex integrates processive RNA polymerase and exonuclease activities.Cooperative translocation enhances the unwinding of duplex DNA by SARS coronavirus helicase nsP13.Metagenomic analysis of the viromes of three North American bat species: viral diversity among different bat species that share a common habitat.Small molecules with antiviral activity against the Ebola virusMiddle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseStructural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.Human coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cellsSHAPE analysis of the RNA secondary structure of the Mouse Hepatitis Virus 5' untranslated region and N-terminal nsp1 coding sequencesGene expression profiles in peripheral blood mononuclear cells of SARS patients.Emerging respiratory viruses: challenges and vaccine strategiesExpression, crystallization and preliminary crystallographic study of the C-terminal half of nsp2 from SARS coronavirus.Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like proteaseThe structure and functions of coronavirus genomic 3' and 5' ends.Role of interferons in the treatment of severe acute respiratory syndrome.
P2860
Q24654956-C531004F-E399-4A03-B033-3A7B70B88A94Q24799739-19735332-AF9F-4830-87BD-7AAAE4C1A42EQ24814670-1471ED7E-525B-466B-AAC1-DF3387991115Q26863163-9F5DA2CA-3125-4B47-8C8E-168C2182E5ACQ27027764-3BBF1ADB-36DA-4866-967A-1ECB9EDF3BD9Q27486794-C92FA6FD-EB1C-4B30-892E-0E9CC9E9B40DQ27489050-4C127184-7599-44CB-B904-735B74451588Q27675849-1BBFDB0B-D2C8-4DFF-A6AC-06865FDD8135Q28395819-BB085018-2082-4F93-B185-B58206543ACBQ30360085-0D47D081-6626-4E88-8FB1-9C23BB526229Q30382717-2A1AA372-3012-488C-8C4E-99AA9938F61AQ30396932-BC44F327-D2CD-4EA2-8DC9-461F4553A445Q30588597-7A5066B3-DC34-4D3F-8FC0-56F95346C46DQ30833734-DC3B2EA5-786C-4DB3-8095-B379F565994DQ30987080-4EEE3845-F1AF-4869-A18C-D8408FB51AE8Q33281855-89DA5B14-4AC2-43FC-8F16-F3D55B806653Q33688229-DDB6B748-8675-44D0-B29C-AC2BC2CB28B0Q33756740-03C7DB60-FFEA-49DE-B76C-BBB0F6E64B00Q33780455-B6BC6B31-572F-4395-AF07-410E2A800D3EQ33841118-C013252D-9001-481A-B6FD-326A9C734324Q33884608-BB4DA48D-C804-4361-84AF-BAF05C73CC48Q33897964-CDEDF104-AD37-4456-9CF5-0A2FBE2977FBQ33987404-C61B8019-4322-467B-9990-8B665100B196Q33991059-38588CB8-265A-4B02-886F-0854E3B8E4C9Q34092818-61D67589-0424-4DB5-BE89-360651594AD0Q34170781-916FD092-269F-4307-8335-EBA5DF43C4ABQ34218422-38CB4E81-748D-417D-9B57-0832B05D2459Q34368072-B126719A-C486-4A49-B32D-5B48AF5D343FQ34416671-DDE90380-2BC4-4B1A-BC65-51F2FA1A0241Q34464403-A145C5AA-C47E-4E13-9C46-776E29FCD23EQ34468689-A4F0E100-A9DE-42EA-BB12-FF4131E9CFD6Q34514760-BB74C141-B001-47B2-9F7B-9228D489BDFBQ34594739-18D48687-411D-4038-8C4B-F8B688067BBDQ34791019-E6E7D3A0-AC17-4AC7-BCEA-E540BAC315BDQ35064521-05F2423A-584F-4BC7-B0C3-3F096FCE45D4Q35070868-60A68FAA-7B3E-4AEB-B1C2-483BEB8D8AEEQ35131311-24F3090B-053E-4D89-8500-53421581C383Q35599437-112BD9F3-F055-4856-8708-E0332D4F3E59Q35768025-5396172A-B86B-4C45-8AD0-3EFED7B2E1BEQ35790834-68188770-73F8-4E66-B60F-D518FCFBD63C
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
SARS--beginning to understand a new virus.
@ast
SARS--beginning to understand a new virus.
@en
type
label
SARS--beginning to understand a new virus.
@ast
SARS--beginning to understand a new virus.
@en
prefLabel
SARS--beginning to understand a new virus.
@ast
SARS--beginning to understand a new virus.
@en
P2093
P2860
P50
P356
P1476
SARS--beginning to understand a new virus.
@en
P2093
Konrad Stadler
Markus Eickmann
Vega Masignani
P2860
P2888
P304
P356
10.1038/NRMICRO775
P407
P577
2003-12-01T00:00:00Z